Zygomycosis in the immunocompromised patient: A case report

Acta Biomedica de l'Ateneo Parmense

Volumn 77, Issue SUPPL. 2, 2006, Pages 5-9

  Georgala, Aspasia ^a   Vekemans, Marc ^a   Husson, Mireille ^a   Meuleman, Nathalie ^a   Beguin, Hugues ^b   Nolard, Nicole ^b   Aoun, Mickael ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

AmBisome ; Haematological malignancy; Zygomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AMSACRINE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CIPROFLOXACIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUCONAZOLE;

ABSIDIA; ACUTE LEUKEMIA; ADULT; ARTICLE; BONE MARROW APLASIA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DOSE RESPONSE; DRUG FORMULATION; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; HUMAN; IMMUNE DEFICIENCY; MUCORMYCOSIS; SINUSITIS;

ABSIDIA; ACUTE DISEASE; AEROSOLS; AMPHOTERICIN B; AMSACRINE; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYTARABINE; DAUNORUBICIN; DEBRIDEMENT; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FLUCONAZOLE; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA; LIPOSOMES; MIDDLE AGED; MUCORMYCOSIS; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845319557     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cornely OA, Maertens J, Bresnik M, Herbrecht R. Liposomal amphotericin B (L-AmB) as initial therapy for invasive filmentous fungal infections (IFFI): A randomised, prospective trial of a high loading regimen vs standard dosing (Ambiload trial) Amercian Society of Heamatology, Atlanta, USA, December 2005.
2. Sugar AM. Mucormycosis. Clin Infect Dis 1992; 14 (suppl. 1): S126-S129.
3. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KVL. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000; 30: 851-4.
4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13 (2): 236-301.
5. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-53.
6. th, Vincet AL, Brantley SG. Nonfatal gastric mucormycosis in a renal transplant recipient. South Med J 1997; 90 (3): 341-4.
7. Nosari A, Oreste P, Montillo M, et al. Mucormycosis in hematologic malingnancies: an emerging fungal infection. Heamatologica 2000; 85 (10): 1068-71.
8. Gonzales CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis 1997; 24 (2): 192-6.
9. Rex JH, Ginsberg AM, Fries LF, Pass HI, Kwon-Chung KJ. Cunninghamella bertholletiae infection associated with deferoxamine therapy. Rev Infect Dis 1988; 10 (6): 1187-94.
10. Prokopowicz GP, Bradley SF, Kauffman CA. Indolent zygomycosis associated with deferoxamine cholation therapy. Mycoses 1994; 37 (11-12): 427-31.
11. Marr AK, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoeitic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-17.
12. Gleisnner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. Improved outcome of zygomycosis in patients with haematological diseases? Leuk Lymphoma 2004; 45 (7): 1351-60.
13. Krcmery VJr, Kunova E, Jesenska Z, et al. Invasive mold infections in cancer patients : 5 years experience with Aspergillus, Mucor, Fusarium and Acremomium infections. Support Care Cancer 1996; 4 (1): 39-45.
14. Hosseini M, Lee J. Gastrointestinal mucormycosis mimicking ischemic colitis in a patient with systemic lupus eruthematosus. Am J Gastroenterol 1998; 93 (8): 1360-2.
15. Hagensee PA, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation : experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19 (3): 402-8.
16. Chopra R. Ambisome in the treatmant of fungal infections: the UK experience. J Antimicrob Chemother 2002; 49 (suppl S1): 43-7.
17. Gonzales CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis 1997; 24: 192-6.
18. Tobon Am, Arango M, Fernandez D, Restrepo A. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient : recovery after posaconazole therapy. Clin Infect Dis 2003; 36 (11): 1488-91.
19. Dannaoui E, Meis JF, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 2003; 47 (11): 3647-50.
20. Leleu X, Sendid B, Fruit J et al. Combined antifungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 24 (4): 417-420.